{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:46:11Z","timestamp":1782971171541,"version":"3.54.5"},"reference-count":182,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-025-01236-0","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:47:41Z","timestamp":1769528861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gut bacteria composition in animal models of Parkinson\u2019s disease: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"12","author":[{"given":"Joshua D.","family":"Elford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise J.","family":"Heesbeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke A.","family":"van der Plaats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Garssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta D.","family":"Kraneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucianne","family":"Groenink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Perez Pardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"1236_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","volume":"403","author":"Y Ben-Shlomo","year":"2024","unstructured":"Ben-Shlomo, Y. et al. The epidemiology of Parkinson\u2019s disease. Lancet 403, 283\u2013292 (2024).","journal-title":"Lancet"},{"key":"1236_CR2","first-page":"1","volume":"7","author":"S Romano","year":"2021","unstructured":"Romano, S. et al. Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation. Npj Park. Dis. 7, 1\u201313 (2021).","journal-title":"Npj Park. Dis."},{"key":"1236_CR3","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/cns.13990","volume":"29","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Gut bacterial profiles in Parkinson\u2019s disease: a systematic review. CNS Neurosci. Ther. 29, 140\u2013157 (2023).","journal-title":"CNS Neurosci. Ther."},{"key":"1236_CR4","doi-asserted-by":"publisher","unstructured":"Markidi, A., Elford, J. D., Berkers, C., Kraneveld, A. D. & Perez-Pardo, P. Gut microbes in Parkinson\u2019s disease: opportunities for microbial-based therapies. in The Gut-Brain Axis 2nd edn (eds Hyland, N. & Stanton, C.) Ch. 9, 217\u2013240 (Academic Press, 2024). https:\/\/doi.org\/10.1016\/B978-0-323-99971-7.00002-3.","DOI":"10.1016\/B978-0-323-99971-7.00002-3"},{"key":"1236_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.neubiorev.2020.02.003","volume":"112","author":"ND Nuzum","year":"2020","unstructured":"Nuzum, N. D. et al. Gut microbiota differences between healthy older adults and individuals with Parkinson\u2019s disease: a systematic review. Neurosci. Biobehav. Rev. 112, 227\u2013241 (2020).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1236_CR6","doi-asserted-by":"publisher","first-page":"109566","DOI":"10.1016\/j.neuropharm.2023.109566","volume":"235","author":"ND Nuzum","year":"2023","unstructured":"Nuzum, N. D. et al. Differences in the gut microbiome across typical ageing and in Parkinson\u2019s disease. Neuropharmacology 235, 109566 (2023).","journal-title":"Neuropharmacology"},{"key":"1236_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13030732","volume":"13","author":"SMS Tran","year":"2021","unstructured":"Tran, S. M. S. & Hasan Mohajeri, M. The role of gut bacterial metabolites in brain development, aging and disease. Nutrients 13, 1\u201341 (2021).","journal-title":"Nutrients"},{"key":"1236_CR8","doi-asserted-by":"crossref","unstructured":"Elford, J. D., Becht, N., Garssen, J., Kraneveld, A. D. & Perez-Pardo, P. Buty and the beast: the complex role of butyrate in Parkinson\u2019s disease. Front. Pharmacol. 15, 1388401 (2024).","DOI":"10.3389\/fphar.2024.1388401"},{"key":"1236_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","volume":"32","author":"MM Unger","year":"2016","unstructured":"Unger, M. M. et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls. Park. Relat. Disord. 32, 66\u201372 (2016).","journal-title":"Park. Relat. Disord."},{"key":"1236_CR10","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/ana.25982","volume":"89","author":"AH Tan","year":"2021","unstructured":"Tan, A. H. et al. Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann. Neurol. 89, 546\u2013559 (2021).","journal-title":"Ann. Neurol."},{"key":"1236_CR11","doi-asserted-by":"publisher","first-page":"E848","DOI":"10.1212\/WNL.0000000000013225","volume":"98","author":"SJ Chen","year":"2022","unstructured":"Chen, S. J. et al. Association of fecal and plasma levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease. Neurology 98, E848\u2013E858 (2022).","journal-title":"Neurology"},{"key":"1236_CR12","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.nbd.2022.105780","volume":"170","author":"RM Voigt","year":"2022","unstructured":"Voigt, R. M. et al. Gut microbial metabolites in Parkinson\u2019s disease: association with lifestyle, disease characteristics, and treatment status. Neurobiol. Dis. 170, 105780 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1236_CR13","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1002\/mds.29063","volume":"37","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Parkinson\u2019s disease is associated with impaired gut-blood barrier for short-chain fatty acids. Mov. Disord. 37, 1634\u20131643 (2022).","journal-title":"Mov. Disord."},{"key":"1236_CR14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","volume":"60","author":"W Li","year":"2017","unstructured":"Li, W. et al. Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features. Sci. China Life Sci. 60, 1223\u20131233 (2017).","journal-title":"Sci. China Life Sci."},{"key":"1236_CR15","doi-asserted-by":"publisher","first-page":"105599","DOI":"10.1016\/j.nbd.2021.105599","volume":"163","author":"N Van Den Berge","year":"2022","unstructured":"Van Den Berge, N. & Ulusoy, A. Animal models of brain-first and body-first Parkinson\u2019s disease. Neurobiol. Dis. 163, 105599 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1236_CR16","doi-asserted-by":"publisher","first-page":"e14604","DOI":"10.1111\/nmo.14604","volume":"35","author":"EJ Videlock","year":"2023","unstructured":"Videlock, E. J., Xing, T., Yehya, A. H. S. & Travagli, R. A. Experimental models of gut-first Parkinson\u2019s disease: a systematic review. Neurogastroenterol. Motil. 35, e14604 (2023).","journal-title":"Neurogastroenterol. Motil."},{"key":"1236_CR17","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3920\/BM2017.0202","volume":"9","author":"P Perez-Pardo","year":"2018","unstructured":"Perez-Pardo, P. et al. Gut bacterial composition in a mouse model of Parkinson\u2019s disease. Benef. Microbes 9, 799\u2013814 (2018).","journal-title":"Benef. Microbes"},{"key":"1236_CR18","doi-asserted-by":"publisher","first-page":"104352","DOI":"10.1016\/j.nbd.2018.12.012","volume":"135","author":"HB Dodiya","year":"2020","unstructured":"Dodiya, H. B. et al. Chronic stress-induced gut dysfunction exacerbates Parkinson\u2019s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson\u2019s disease. Neurobiol. Dis. 135, 104352 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1236_CR19","doi-asserted-by":"crossref","unstructured":"Cao, X. et al. Low and high doses of oral maslinic acid protect against Parkinson\u2019s disease via distinct gut microbiota-related mechanisms. Biomed. Pharmacother. 165, 115100 (2023).","DOI":"10.1016\/j.biopha.2023.115100"},{"key":"1236_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bbi.2018.02.005","volume":"70","author":"M-F Sun","year":"2018","unstructured":"Sun, M.-F. et al. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson\u2019s disease mice: gut microbiota, glial reaction and TLR4\/TNF-\u03b1 signaling pathway. Brain Behav. Immun. 70, 48\u201360 (2018).","journal-title":"Brain Behav. Immun."},{"key":"1236_CR21","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.bbi.2020.10.014","volume":"91","author":"J Sun","year":"2021","unstructured":"Sun, J. et al. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson\u2019s disease via gut microbiota-GLP-1 pathway. Brain Behav. Immun. 91, 703\u2013715 (2021).","journal-title":"Brain Behav. Immun."},{"key":"1236_CR22","doi-asserted-by":"publisher","first-page":"808905","DOI":"10.3389\/fcell.2021.808905","volume":"9","author":"Z Sun","year":"2022","unstructured":"Sun, Z. et al. Human umbilical cord mesenchymal stem cells improve locomotor function in Parkinson\u2019s disease mouse model through regulating intestinal microorganisms. Front. Cell Dev. Biol. 9, 808905 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"1236_CR23","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1039\/D3FO03667G","volume":"15","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. Integrated multi-omics profiling highlights the benefits of resveratrol hydroxypropyl-\u03b2-cyclodextrin inclusion complex for A53T transgenic mice through the microbiota\u2013gut\u2013brain axis. Food Funct. 15, 1489\u20131512 (2024).","journal-title":"Food Funct."},{"key":"1236_CR24","doi-asserted-by":"publisher","first-page":"e0217194","DOI":"10.1371\/journal.pone.0217194","volume":"14","author":"JG Choi","year":"2019","unstructured":"Choi, J. G., Huh, E., Kim, N., Kim, D.-H. & Oh, M. S. High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment. PLoS ONE 14, e0217194 (2019).","journal-title":"PLoS ONE"},{"key":"1236_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/jnc.14694","volume":"150","author":"X Fang","year":"2019","unstructured":"Fang, X., Tian, P., Zhao, X., Jiang, C. & Chen, T. Neuroprotective effects of an engineered commensal bacterium in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine Parkinson disease mouse model via producing glucagon-like peptide-1. J. Neurochem. 150, 441\u2013452 (2019).","journal-title":"J. Neurochem."},{"key":"1236_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-020-01014-6","volume":"10","author":"X Fang","year":"2020","unstructured":"Fang, X. et al. Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer\u2019s disease and Parkinson\u2019s disease. AMB Express 10, 80 (2020).","journal-title":"AMB Express"},{"key":"1236_CR27","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.4103\/1673-5374.391191","volume":"19","author":"X Fang","year":"2024","unstructured":"Fang, X. et al. Gut microbiota dysbiosis contributes to \u03b1-synuclein-related pathology associated with C\/EBP\u03b2\/AEP signaling activation in a mouse model of Parkinson\u2019s disease. Neural Regen. Res. 19, 2081 (2024).","journal-title":"Neural Regen. Res."},{"key":"1236_CR28","doi-asserted-by":"crossref","unstructured":"Gorecki, A. M. et al. Altered gut microbiome in Parkinson\u2019s disease and the influence of lipopolysaccharide in a human \u03b1-synuclein over-expressing mouse model. Front. Neurosci. 13, 839 (2019).","DOI":"10.3389\/fnins.2019.00839"},{"key":"1236_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/gutjnl-2018-316844","volume":"68","author":"P Perez-Pardo","year":"2019","unstructured":"Perez-Pardo, P. et al. Role of TLR4 in the gut-brain axis in Parkinson\u2019s disease: a translational study from men to mice. Gut 68, 829\u2013843 (2019).","journal-title":"Gut"},{"key":"1236_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s13311-019-00719-2","volume":"16","author":"Z-L Zhou","year":"2019","unstructured":"Zhou, Z.-L. et al. Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson\u2019s disease mice via gut microbiota and metabolites. Neurotherapeutics 16, 741\u2013760 (2019).","journal-title":"Neurotherapeutics"},{"key":"1236_CR31","doi-asserted-by":"publisher","first-page":"9424582","DOI":"10.1155\/2021\/9424582","volume":"2021","author":"X Zhou","year":"2021","unstructured":"Zhou, X. et al. Neuroprotective effect of ceftriaxone on MPTP-induced Parkinson\u2019s disease mouse model by regulating inflammation and intestinal microbiota. Oxid. Med. Cell. Longev. 2021, 9424582 (2021).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"1236_CR32","doi-asserted-by":"publisher","first-page":"105661","DOI":"10.1016\/j.neuint.2023.105661","volume":"173","author":"X Zhou","year":"2024","unstructured":"Zhou, X. et al. The intestinal microbiota exerts a sex-specific influence on neuroinflammation in a Parkinson\u2019s disease mouse model. Neurochem. Int. 173, 105661 (2024).","journal-title":"Neurochem. Int."},{"key":"1236_CR33","doi-asserted-by":"publisher","first-page":"112299","DOI":"10.1016\/j.jep.2019.112299","volume":"247","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. Protective role of cinnabar and realgar in Hua-Feng-Dan against LPS plus rotenone-induced neurotoxicity and disturbance of gut microbiota in rats. J. Ethnopharmacol. 247, 112299 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"1236_CR34","doi-asserted-by":"publisher","first-page":"549037","DOI":"10.3389\/fnins.2020.549037","volume":"14","author":"T-J Chen","year":"2020","unstructured":"Chen, T.-J. et al. Fisetin regulates gut microbiota and exerts neuroprotective effect on mouse model of Parkinson\u2019s disease. Front. Neurosci. 14, 549037 (2020).","journal-title":"Front. Neurosci."},{"key":"1236_CR35","doi-asserted-by":"publisher","first-page":"842380","DOI":"10.3389\/fnagi.2022.842380","volume":"14","author":"A-D Chen","year":"2022","unstructured":"Chen, A.-D. et al. Rotenone aggravates PD-like pathology in A53T mutant human \u03b1-synuclein transgenic mice in an age-dependent manner. Front. Aging Neurosci. 14, 842380 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1236_CR36","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.ijbiomac.2020.07.180","volume":"164","author":"X-L Dong","year":"2020","unstructured":"Dong, X.-L. et al. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson\u2019s disease model. Int. J. Biol. Macromol. 164, 994\u20131005 (2020).","journal-title":"Int. J. Biol. Macromol."},{"key":"1236_CR37","doi-asserted-by":"publisher","first-page":"7534","DOI":"10.1007\/s12035-024-04038-2","volume":"61","author":"Y Dong","year":"2024","unstructured":"Dong, Y. et al. Neuroprotective effects of bifidobacterium animalis subsp. lactis NJ241 in a mouse model of Parkinson\u2019s disease: implications for gut microbiota and PGC-1\u03b1. Mol. Neurobiol. 61, 7534\u20137548 (2024).","journal-title":"Mol. Neurobiol."},{"key":"1236_CR38","doi-asserted-by":"publisher","first-page":"112674","DOI":"10.1016\/j.jep.2020.112674","volume":"254","author":"A-L Hu","year":"2020","unstructured":"Hu, A.-L. et al. Mercury sulfide-containing Hua-Feng-Dan and 70\u2009W (Rannasangpei) protect against LPS plus MPTP-induced neurotoxicity and disturbance of gut microbiota in mice. J. Ethnopharmacol. 254, 112674 (2020).","journal-title":"J. Ethnopharmacol."},{"key":"1236_CR39","doi-asserted-by":"publisher","first-page":"116893","DOI":"10.1016\/j.jep.2023.116893","volume":"318","author":"J Hu","year":"2024","unstructured":"Hu, J. et al. Alterations of gut microbiota and its correlation with the liver metabolome in the process of ameliorating Parkinson\u2019s disease with Buyang Huanwu decoction. J. Ethnopharmacol. 318, 116893 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"1236_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbi.2020.08.015","volume":"89","author":"J-H Jang","year":"2020","unstructured":"Jang, J.-H. et al. Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson\u2019s disease. Brain Behav. Immun. 89, 641\u2013655 (2020).","journal-title":"Brain Behav. Immun."},{"key":"1236_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbi.2020.07.036","volume":"90","author":"J-F Liao","year":"2020","unstructured":"Liao, J.-F. et al. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson\u2019s disease. Brain Behav. Immun. 90, 26\u201346 (2020).","journal-title":"Brain Behav. Immun."},{"key":"1236_CR42","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1096\/fj.201903125RR","volume":"34","author":"Y Xu","year":"2020","unstructured":"Xu, Y. et al. EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson\u2019s disease. FASEB J. 34, 5931\u20135950 (2020).","journal-title":"FASEB J."},{"key":"1236_CR43","doi-asserted-by":"publisher","first-page":"110729","DOI":"10.1016\/j.brainresbull.2023.110729","volume":"202","author":"Z Xu","year":"2023","unstructured":"Xu, Z. et al. N-acetyl-L-leucine protects MPTP-treated Parkinson\u2019s disease mouse models by suppressing Desulfobacterota via the gut-brain axis. Brain Res. Bull. 202, 110729 (2023).","journal-title":"Brain Res. Bull."},{"key":"1236_CR44","doi-asserted-by":"publisher","first-page":"3366","DOI":"10.1021\/acschemneuro.0c00475","volume":"11","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y. et al. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson\u2019s disease in mouse: potential association between neurotransmitter disturbance and gut microbiota dysbiosis. ACS Chem. Neurosci. 11, 3366\u20133376 (2020).","journal-title":"ACS Chem. Neurosci."},{"key":"1236_CR45","doi-asserted-by":"publisher","first-page":"9110560","DOI":"10.1155\/2022\/9110560","volume":"2022","author":"H Zhu","year":"2022","unstructured":"Zhu, H. et al. Curcumin regulates gut microbiota and exerts a neuroprotective effect in the MPTP model of Parkinson\u2019s disease. Evid. Based Complement. Altern. Med. 2022, 9110560 (2022).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"1236_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02062-2","volume":"18","author":"Z Dwyer","year":"2021","unstructured":"Dwyer, Z. et al. The impact of dextran sodium sulphate and probiotic pre-treatment in a murine model of Parkinson\u2019s disease. J. Neuroinflammation 18, 20 (2021).","journal-title":"J. Neuroinflammation"},{"key":"1236_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00988-6","volume":"9","author":"Y Hou","year":"2021","unstructured":"Hou, Y. et al. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson\u2019s disease. Microbiome 9, 34 (2021).","journal-title":"Microbiome"},{"key":"1236_CR48","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.bbi.2021.02.028","volume":"94","author":"H Jeon","year":"2021","unstructured":"Jeon, H., Bae, C.-H., Lee, Y., Kim, H.-Y. & Kim, S. Korean red ginseng suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced inflammation in the substantia nigra and colon. Brain Behav. Immun. 94, 410\u2013423 (2021).","journal-title":"Brain Behav. Immun."},{"key":"1236_CR49","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1007\/s11064-021-03293-2","volume":"46","author":"X Liu","year":"2021","unstructured":"Liu, X. et al. Intragastric administration of casein leads to nigrostriatal disease progressed accompanied with persistent nigrostriatal\u2014intestinal inflammation activited and intestinal microbiota\u2014metabolic disorders induced in MPTP mouse model of Parkinson\u2019s disease. Neurochem. Res. 46, 1514\u20131539 (2021).","journal-title":"Neurochem. Res."},{"key":"1236_CR50","doi-asserted-by":"crossref","unstructured":"Liu, X. et al. Colonic dopaminergic neurons changed reversely with those in the midbrain via gut microbiota-mediated autophagy in a chronic Parkinson\u2019s disease mice model. Front. Aging Neurosci. 13, 649627 (2021).","DOI":"10.3389\/fnagi.2021.649627"},{"key":"1236_CR51","doi-asserted-by":"publisher","first-page":"111067","DOI":"10.1016\/j.foodres.2022.111067","volume":"155","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Polymannuronic acid prebiotic plus Lacticaseibacillus rhamnosus GG probiotic as a novel synbiotic promoted their separate neuroprotection against Parkinson\u2019s disease. Food Res. Int. 155, 111067 (2022).","journal-title":"Food Res. Int."},{"key":"1236_CR52","doi-asserted-by":"publisher","first-page":"936818","DOI":"10.3389\/fphar.2022.936818","volume":"13","author":"M-M Liu","year":"2022","unstructured":"Liu, M.-M. et al. Neuroprotective effects of oligosaccharides from periplaneta Americana on Parkinson\u2019s disease models in vitro and in vivo. Front. Pharmacol. 13, 936818 (2022).","journal-title":"Front. Pharmacol."},{"key":"1236_CR53","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40035-022-00318-w","volume":"11","author":"W Liu","year":"2022","unstructured":"Liu, W., Lim, K.-L. & Tan, E.-K. Intestine-derived \u03b1-synuclein initiates and aggravates pathogenesis of Parkinson\u2019s disease in Drosophila. Transl. Neurodegener. 11, 44 (2022).","journal-title":"Transl. Neurodegener."},{"key":"1236_CR54","doi-asserted-by":"publisher","first-page":"13676","DOI":"10.1021\/acs.jafc.2c06429","volume":"70","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al. Fucosylated Chondroitin Sulfate against Parkinson\u2019s Disease through Inhibiting Inflammation Induced by Gut Dysbiosis. J. Agric. Food Chem. 70, 13676\u201313691 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"1236_CR55","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1021\/acs.jafc.1c06998","volume":"70","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Effect of coffee against MPTP-induced motor deficits and neurodegeneration in mice via regulating gut microbiota. J. Agric. Food Chem. 70, 184\u2013195 (2022).","journal-title":"J. Agric. Food Chem."},{"key":"1236_CR56","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.bbi.2024.01.010","volume":"117","author":"J Liu","year":"2024","unstructured":"Liu, J. et al. Microbiota-microglia crosstalk between Blautia producta and neuroinflammation of Parkinson\u2019s disease: a bench-to-bedside translational approach. Brain Behav. Immun. 117, 270\u2013282 (2024).","journal-title":"Brain Behav. Immun."},{"key":"1236_CR57","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.apsb.2021.01.009","volume":"11","author":"J Shang","year":"2021","unstructured":"Shang, J. et al. Gut microbiota mediates the absorption of FLZ, a new drug for Parkinson\u2019s disease treatment. Acta Pharm. Sin. B 11, 1213\u20131226 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"1236_CR58","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.3390\/antiox10111823","volume":"10","author":"S-P Tsao","year":"2021","unstructured":"Tsao, S.-P. et al. Probiotic enhancement of antioxidant capacity and alterations of gut microbiota composition in 6-hydroxydopamin-induced Parkinson\u2019s disease rats. Antioxidants 10, 1823 (2021).","journal-title":"Antioxidants"},{"key":"1236_CR59","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1016\/j.apsb.2021.03.020","volume":"11","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Novel compound FLZ alleviates rotenone-induced PD mouse model by suppressing TLR4\/MyD88\/NF-\u03baB pathway through microbiota\u2013gut\u2013brain axis. Acta Pharm. Sin. B 11, 2859\u20132879 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"1236_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01107-9","volume":"9","author":"Z Zhao","year":"2021","unstructured":"Zhao, Z. et al. Fecal microbiota transplantation protects rotenone-induced Parkinson\u2019s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis. Microbiome 9, 226 (2021).","journal-title":"Microbiome"},{"key":"1236_CR61","doi-asserted-by":"publisher","first-page":"6367","DOI":"10.3390\/ijms23126367","volume":"23","author":"C Avagliano","year":"2022","unstructured":"Avagliano, C. et al. Dual-hit model of Parkinson\u2019s disease: impact of dysbiosis on 6-hydroxydopamine-insulted mice\u2014neuroprotective and anti-inflammatory effects of butyrate. Int. J. Mol. Sci. 23, 6367 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1236_CR62","doi-asserted-by":"publisher","first-page":"887407","DOI":"10.3389\/fcimb.2022.887407","volume":"12","author":"C Cui","year":"2022","unstructured":"Cui, C. et al. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson\u2019s disease. Front. Cell. Infect. Microbiol. 12, 887407 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1236_CR63","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11481-023-10085-8","volume":"18","author":"C Cui","year":"2023","unstructured":"Cui, C. et al. 5-HT4 receptor is protective for MPTP-induced Parkinson\u2019s disease mice via altering gastrointestinal motility or gut microbiota. J. Neuroimmune Pharmacol. 18, 610\u2013627 (2023).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"1236_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11481-021-10047-y","volume":"18","author":"C Cui","year":"2023","unstructured":"Cui, C. et al. Vancomycin pretreatment on MPTP-induced Parkinson\u2019s disease mice exerts neuroprotection by suppressing inflammation both in brain and gut. J. Neuroimmune Pharmacol. 18, 72\u201389 (2023).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"1236_CR65","doi-asserted-by":"publisher","first-page":"e00431","DOI":"10.1128\/msphere.00431-23","volume":"8","author":"C Cui","year":"2023","unstructured":"Cui, C. et al. Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson\u2019s disease. mSphere 8, e00431\u201323 (2023).","journal-title":"mSphere"},{"key":"1236_CR66","doi-asserted-by":"publisher","first-page":"e10455","DOI":"10.1002\/btm2.10455","volume":"8","author":"H Fan","year":"2022","unstructured":"Fan, H. et al. Heat-killed Lactobacillus murinus confers neuroprotection against dopamine neuronal loss by targeting NLRP3 inflammasome. Bioeng. Transl. Med. 8, e10455 (2022).","journal-title":"Bioeng. Transl. Med."},{"key":"1236_CR67","doi-asserted-by":"publisher","first-page":"882628","DOI":"10.3389\/fneur.2022.882628","volume":"13","author":"A Jackson","year":"2022","unstructured":"Jackson, A. et al. Intestinal barrier dysfunction in the absence of systemic inflammation fails to exacerbate motor dysfunction and brain pathology in a mouse model of Parkinson\u2019s disease. Front. Neurol. 13, 882628 (2022).","journal-title":"Front. Neurol."},{"key":"1236_CR68","doi-asserted-by":"publisher","first-page":"4678","DOI":"10.3390\/nu14214678","volume":"14","author":"T Li","year":"2022","unstructured":"Li, T. et al. Neuroprotective effects of bifidobacterium breve CCFM1067 in MPTP-induced mouse models of Parkinson\u2019s disease. Nutrients 14, 4678 (2022).","journal-title":"Nutrients"},{"key":"1236_CR69","doi-asserted-by":"publisher","first-page":"945356","DOI":"10.3389\/fnut.2022.945356","volume":"9","author":"D Li","year":"2023","unstructured":"Li, D. et al. Mechanisms of the Ping-wei-san plus herbal decoction against Parkinson\u2019s disease: multiomics analyses. Front. Nutr. 9, 945356 (2023).","journal-title":"Front. Nutr."},{"key":"1236_CR70","doi-asserted-by":"publisher","first-page":"e371104","DOI":"10.1590\/acb371104","volume":"37","author":"J Li","year":"2023","unstructured":"Li, J., Ni, Y., Huang, L., Yu, X. & Zhu, J. Er-Bai-Tang decoction improved the movement disorders and neuronal injury in the Parkinson\u2019s disease model rats via decreasing p38 MAPK pathway and improving the composition of intestinal flora. Acta Cir. Bras. 37, e371104 (2023).","journal-title":"Acta Cir. Bras."},{"key":"1236_CR71","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.3390\/antiox11122396","volume":"11","author":"BA Nurrahma","year":"2022","unstructured":"Nurrahma, B. A. et al. Mangosteen pericarp extract supplementation boosts antioxidant status via rebuilding gut microbiota to attenuate motor deficit in 6-OHDA-induced Parkinson\u2019s disease. Antioxidants 11, 2396 (2022).","journal-title":"Antioxidants"},{"key":"1236_CR72","doi-asserted-by":"publisher","first-page":"1022879","DOI":"10.3389\/fcimb.2022.1022879","volume":"12","author":"S Pan","year":"2022","unstructured":"Pan, S. et al. Probiotic Pediococcus pentosaceus ameliorates MPTP-induced oxidative stress via regulating the gut microbiota\u2013gut\u2013brain axis. Front. Cell. Infect. Microbiol. 12, 1022879 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1236_CR73","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1039\/D1FO02216D","volume":"13","author":"N Wang","year":"2022","unstructured":"Wang, N. et al. Neuroprotection of chicoric acid in a mouse model of Parkinson\u2019s disease involves gut microbiota and TLR4 signaling pathway. Food Funct. 13, 2019\u20132032 (2022).","journal-title":"Food Funct."},{"key":"1236_CR74","doi-asserted-by":"publisher","first-page":"877078","DOI":"10.3389\/fnagi.2022.877078","volume":"14","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Multi-omics integration in mice with Parkinson\u2019s disease and the intervention effect of cyanidin-3-O-glucoside. Front. Aging Neurosci. 14, 877078 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1236_CR75","doi-asserted-by":"publisher","first-page":"e10505","DOI":"10.1002\/btm2.10505","volume":"8","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Neuroprotective effect of engineered Clostridium butyricum-pMTL007-GLP-1 on Parkinson\u2019s disease mice models via promoting mitophagy. Bioeng. Transl. Med. 8, e10505 (2023).","journal-title":"Bioeng. Transl. Med."},{"key":"1236_CR76","doi-asserted-by":"publisher","first-page":"114240","DOI":"10.1016\/j.bbr.2022.114240","volume":"439","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Exercise training has a protective effect in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model with improved neural and intestinal pathology and modified intestinal flora. Behav. Brain Res. 439, 114240 (2023).","journal-title":"Behav. Brain Res."},{"key":"1236_CR77","doi-asserted-by":"publisher","first-page":"e10351","DOI":"10.1002\/btm2.10351","volume":"8","author":"H Wu","year":"2022","unstructured":"Wu, H. et al. Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson\u2019s disease in mice by delivering GLP-1 and modulating gut microbiota. Bioeng. Transl. Med. 8, e10351 (2022).","journal-title":"Bioeng. Transl. Med."},{"key":"1236_CR78","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1007\/s11011-022-01004-6","volume":"37","author":"Z Yan","year":"2022","unstructured":"Yan, Z., Li, R., Shi, W. & Yao, L. Role of the gut-microbiota-metabolite axis in the rotenone model of early-stage Parkinson\u2019s Disease. Metab. Brain Dis. 37, 2511\u20132520 (2022).","journal-title":"Metab. Brain Dis."},{"key":"1236_CR79","doi-asserted-by":"publisher","first-page":"4886","DOI":"10.3390\/nu14224886","volume":"14","author":"M Yue","year":"2022","unstructured":"Yue, M. et al. Neurotrophic role of the next-generation probiotic strain L. lactis MG1363-pMG36e-GLP-1 on Parkinson\u2019s disease via inhibiting ferroptosis. Nutrients 14, 4886 (2022).","journal-title":"Nutrients"},{"key":"1236_CR80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3892\/etm.2021.10974","volume":"23","author":"T Zhang","year":"2022","unstructured":"Zhang, T., Wang, T., Chen, X., Zhao, Z. & Chen, Z. Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson\u2019s disease by protecting the function of dopamine neurons. Exp. Ther. Med. 23, 52 (2022).","journal-title":"Exp. Ther. Med."},{"key":"1236_CR81","doi-asserted-by":"publisher","first-page":"1099018","DOI":"10.3389\/fnagi.2023.1099018","volume":"15","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson\u2019s disease by regulating gut microbiota. Front. Aging Neurosci. 15, 1099018 (2023).","journal-title":"Front. Aging Neurosci."},{"key":"1236_CR82","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41420-023-01549-0","volume":"9","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Neuroprotective effect of a medium-chain triglyceride ketogenic diet on MPTP-induced Parkinson\u2019s disease mice: a combination of transcriptomics and metabolomics in the substantia nigra and fecal microbiome. Cell Death Discov. 9, 251 (2023).","journal-title":"Cell Death Discov."},{"key":"1236_CR83","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00018-023-04807-7","volume":"80","author":"W Zhang","year":"2023","unstructured":"Zhang, W. et al. Dietary intake of \u03b1-ketoglutarate ameliorates \u03b1-synuclein pathology in mouse models of Parkinson\u2019s disease. Cell. Mol. Life Sci. 80, 155 (2023).","journal-title":"Cell. Mol. Life Sci."},{"key":"1236_CR84","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1007\/s10571-023-01319-7","volume":"43","author":"B Aktas","year":"2023","unstructured":"Aktas, B. Gut Microbial alteration in MPTP mouse model of Parkinson disease is administration regimen dependent. Cell. Mol. Neurobiol. 43, 2815\u20132829 (2023).","journal-title":"Cell. Mol. Neurobiol."},{"key":"1236_CR85","doi-asserted-by":"publisher","first-page":"1198335","DOI":"10.3389\/fphar.2023.1198335","volume":"14","author":"B Cai","year":"2023","unstructured":"Cai, B. et al. Curcumin alleviates 1-methyl- 4-phenyl- 1,2,3,6-tetrahydropyridine- induced Parkinson\u2019s disease in mice via modulating gut microbiota and short-chain fatty acids. Front. Pharmacol. 14, 1198335 (2023).","journal-title":"Front. Pharmacol."},{"key":"1236_CR86","doi-asserted-by":"publisher","first-page":"8877","DOI":"10.1021\/acs.jafc.2c07606","volume":"71","author":"C Chu","year":"2023","unstructured":"Chu, C. et al. A low-protein, high-carbohydrate diet exerts a neuroprotective effect on mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease by regulating the microbiota-metabolite\u2013brain axis and fibroblast growth factor 21. J. Agric. Food Chem. 71, 8877\u20138893 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"1236_CR87","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.3390\/nu15071737","volume":"15","author":"C Chu","year":"2023","unstructured":"Chu, C. et al. Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson\u2019s disease mice via regulating gut microbiota and branched-chain amino acids biosynthesis. Nutrients 15, 1737 (2023).","journal-title":"Nutrients"},{"key":"1236_CR88","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41531-023-00582-1","volume":"9","author":"J Grigoletto","year":"2023","unstructured":"Grigoletto, J. et al. Velusetrag rescues GI dysfunction, gut inflammation and dysbiosis in a mouse model of Parkinson\u2019s disease. Npj Park. Dis. 9, 140 (2023).","journal-title":"Npj Park. Dis."},{"key":"1236_CR89","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3390\/nu15040930","volume":"15","author":"T-T Guo","year":"2023","unstructured":"Guo, T.-T. et al. Neuroprotective effects of sodium butyrate by restoring gut microbiota and inhibiting TLR4 signaling in mice with MPTP-induced Parkinson\u2019s disease. Nutrients 15, 930 (2023).","journal-title":"Nutrients"},{"key":"1236_CR90","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1007\/s11064-023-04004-9","volume":"48","author":"Z He","year":"2023","unstructured":"He, Z., Huan, P., Wang, L. & He, J. Compound dihuang granule changes gut microbiota of MPTP-induced Parkinson\u2019s disease mice via inhibiting TLR4\/NF-\u03baB signaling. Neurochem. Res. 48, 3610\u20133624 (2023).","journal-title":"Neurochem. Res."},{"key":"1236_CR91","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1039\/D3FO04714H","volume":"15","author":"D He","year":"2024","unstructured":"He, D. et al. Orally administered neohesperidin attenuates MPTP-induced neurodegeneration by inhibiting inflammatory responses and regulating intestinal flora in mice. Food Funct. 15, 1460\u20131475 (2024).","journal-title":"Food Funct."},{"key":"1236_CR92","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1002\/mco2.268","volume":"4","author":"Z Jiang","year":"2023","unstructured":"Jiang, Z. et al. Ketogenic diet protects MPTP-induced mouse model of Parkinson\u2019s disease via altering gut microbiota and metabolites. MedComm 4, e268 (2023).","journal-title":"MedComm"},{"key":"1236_CR93","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s42826-023-00181-4","volume":"39","author":"JE Kim","year":"2023","unstructured":"Kim, J. E. et al. Compositional changes in fecal microbiota in a new Parkinson\u2019s disease model: C57BL\/6-Tg(NSE-haSyn) mice. Lab. Anim. Res. 39, 30 (2023).","journal-title":"Lab. Anim. Res."},{"key":"1236_CR94","doi-asserted-by":"publisher","first-page":"6794","DOI":"10.3390\/ijms24076794","volume":"24","author":"YZ Lee","year":"2023","unstructured":"Lee, Y. Z. et al. Neuroprotective effects of Lactobacillus plantarum PS128 in a mouse model of Parkinson\u2019s disease: the role of gut microbiota and MicroRNAs. Int. J. Mol. Sci. 24, 6794 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1236_CR95","doi-asserted-by":"publisher","first-page":"e18045","DOI":"10.1016\/j.heliyon.2023.e18045","volume":"9","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. Acanthopanax senticosus Harms improves Parkinson\u2019s disease by regulating gut microbial structure and metabolic disorders. Heliyon 9, e18045 (2023).","journal-title":"Heliyon"},{"key":"1236_CR96","doi-asserted-by":"publisher","first-page":"117182","DOI":"10.1016\/j.jep.2023.117182","volume":"319","author":"Y Lu","year":"2024","unstructured":"Lu, Y. et al. Efficacy and mechanism study of Baichanting compound, a combination of Acanthopanax senticosus (Rupr. and Maxim.) Harms, Paeonia lactiflora Pall and Uncaria rhynchophylla (Miq.) Miq. ex Havil, on Parkinson\u2019s disease based on metagenomics and metabolomics. J. Ethnopharmacol. 319, 117182 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"1236_CR97","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.jpha.2023.06.007","volume":"13","author":"Z Mao","year":"2023","unstructured":"Mao, Z. et al. Protective effects of dioscin against Parkinson\u2019s disease via regulating bile acid metabolism through remodeling gut microbiome\/GLP-1 signaling. J. Pharm. Anal. 13, 1153\u20131167 (2023).","journal-title":"J. Pharm. Anal."},{"key":"1236_CR98","doi-asserted-by":"publisher","first-page":"109573","DOI":"10.1016\/j.neuropharm.2023.109573","volume":"236","author":"D Molina-Mateo","year":"2023","unstructured":"Molina-Mateo, D. et al. Kanamycin treatment in the pre-symptomatic stage of a Drosophila PD model prevents the onset of non-motor alterations. Neuropharmacology 236, 109573 (2023).","journal-title":"Neuropharmacology"},{"key":"1236_CR99","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neuroscience.2023.05.014","volume":"524","author":"Z Pu","year":"2023","unstructured":"Pu, Z. et al. Casein reactivates dopaminergic nerve injury and intestinal inflammation with disturbing intestinal microflora and fecal metabolites in a convalescent Parkinson\u2019s disease mouse model. Neuroscience 524, 120\u2013136 (2023).","journal-title":"Neuroscience"},{"key":"1236_CR100","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1039\/D2FO03379H","volume":"14","author":"J Tao","year":"2023","unstructured":"Tao, J. et al. The protective role of microbiota in the prevention of MPTP\/P-induced Parkinson\u2019s disease by resveratrol. Food Funct. 14, 4647\u20134661 (2023).","journal-title":"Food Funct."},{"key":"1236_CR101","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.14336\/AD.2023.0309","volume":"14","author":"Z Xie","year":"2023","unstructured":"Xie, Z. et al. Healthy human fecal microbiota transplantation into mice attenuates MPTP-induced neurotoxicity via AMPK\/SOD2 pathway. Aging Dis. 14, 2193\u20132214 (2023).","journal-title":"Aging Dis."},{"key":"1236_CR102","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1111\/cns.14302","volume":"29","author":"C Yang","year":"2023","unstructured":"Yang, C. et al. Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson\u2019s disease mouse model via modulating gut microbiota and metabolic homeostasis. CNS Neurosci. Ther. 29, 3815\u20133828 (2023).","journal-title":"CNS Neurosci. Ther."},{"key":"1236_CR103","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41401-023-01150-2","volume":"45","author":"Z Yang","year":"2024","unstructured":"Yang, Z. et al. Addition of \u03b1-synuclein aggregates to the intestinal environment recapitulates Parkinsonian symptoms in model systems. Acta Pharmacol. Sin. 45, 36\u201351 (2024).","journal-title":"Acta Pharmacol. Sin."},{"key":"1236_CR104","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1039\/D3FO05169B","volume":"15","author":"Q Gan","year":"2024","unstructured":"Gan, Q. et al. Gastrodia elata polysaccharide alleviates Parkinson\u2019s disease via inhibiting apoptotic and inflammatory signaling pathways and modulating the gut microbiota. Food Funct. 15, 2920\u20132938 (2024).","journal-title":"Food Funct."},{"key":"1236_CR105","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41401-023-01147-x","volume":"45","author":"X Ma","year":"2024","unstructured":"Ma, X. et al. Gut microbiota-induced CXCL1 elevation triggers early neuroinflammation in the substantia nigra of Parkinsonian mice. Acta Pharmacol. Sin. 45, 52\u201365 (2024).","journal-title":"Acta Pharmacol. Sin."},{"key":"1236_CR106","doi-asserted-by":"publisher","first-page":"155309","DOI":"10.1016\/j.phymed.2023.155309","volume":"124","author":"T Meng","year":"2024","unstructured":"Meng, T. et al. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson\u2019s disease, and alters gut microbiota and metabolite composition. Phytomedicine 124, 155309 (2024).","journal-title":"Phytomedicine"},{"key":"1236_CR107","doi-asserted-by":"publisher","first-page":"117628","DOI":"10.1016\/j.jep.2023.117628","volume":"322","author":"L Yu","year":"2024","unstructured":"Yu, L. et al. Piperine promotes PI3K\/AKT\/mTOR-mediated gut-brain autophagy to degrade \u03b1-Synuclein in Parkinson\u2019s disease rats. J. Ethnopharmacol. 322, 117628 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"1236_CR108","doi-asserted-by":"publisher","first-page":"e81453","DOI":"10.7554\/eLife.81453","volume":"11","author":"R Abdel-Haq","year":"2022","unstructured":"Abdel-Haq, R. et al. A prebiotic diet modulates microglial states and motor deficits in \u03b1-synuclein overexpressing mice. eLife 11, e81453 (2022).","journal-title":"eLife"},{"key":"1236_CR109","doi-asserted-by":"publisher","first-page":"1866974","DOI":"10.1080\/19490976.2020.1866974","volume":"13","author":"Y Bhattarai","year":"2021","unstructured":"Bhattarai, Y. et al. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson\u2019s disease. Gut Microbes 13, 1866974 (2021).","journal-title":"Gut Microbes"},{"key":"1236_CR110","doi-asserted-by":"publisher","first-page":"288","DOI":"10.55730\/1300-0152.2617","volume":"46","author":"T Fan","year":"2022","unstructured":"Fan, T. et al. Influence of aerobic exercise training on mice gut microbiota in Parkinson\u2019s disease. Turk. J. Biol. 46, 288\u2013297 (2022).","journal-title":"Turk. J. Biol."},{"key":"1236_CR111","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su, D. et al. Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388, e080952 (2025).","journal-title":"BMJ"},{"key":"1236_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-014-0050-9","volume":"2","author":"MG Langille","year":"2014","unstructured":"Langille, M. G. et al. Microbial shifts in the aging mouse gut. Microbiome 2, 50 (2014).","journal-title":"Microbiome"},{"key":"1236_CR113","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1177\/0023677216653984","volume":"51","author":"SJ Jackson","year":"2017","unstructured":"Jackson, S. J. et al. Does age matter? The impact of rodent age on study outcomes. Lab. Anim. 51, 160\u2013169 (2017).","journal-title":"Lab. Anim."},{"key":"1236_CR114","doi-asserted-by":"publisher","unstructured":"Xia, Y. & Sun, J. Alpha Diversity. in Bioinformatic and Statistical Analysis of Microbiome Data: From Raw Sequences to Advanced Modeling with QIIME 2 and R (eds Xia, Y. & Sun, J.) 289\u2013333. https:\/\/doi.org\/10.1007\/978-3-031-21391-5_9 (Springer International Publishing, Cham, 2023).","DOI":"10.1007\/978-3-031-21391-5_9"},{"key":"1236_CR115","doi-asserted-by":"publisher","first-page":"e0142164","DOI":"10.1371\/journal.pone.0142164","volume":"10","author":"S Hasegawa","year":"2015","unstructured":"Hasegawa, S. et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s Disease. PLoS ONE 10, e0142164 (2015).","journal-title":"PLoS ONE"},{"key":"1236_CR116","first-page":"1","volume":"6","author":"ZD Wallen","year":"2020","unstructured":"Wallen, Z. D. et al. Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens. Npj Park. Dis. 6, 1\u201312 (2020).","journal-title":"Npj Park. Dis."},{"key":"1236_CR117","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s12264-023-01123-9","volume":"40","author":"W-X Duan","year":"2024","unstructured":"Duan, W.-X., Wang, F., Liu, J.-Y. & Liu, C.-F. Relationship between short-chain fatty acids and parkinson\u2019s disease: a review from pathology to clinic. Neurosci. Bull. 40, 500\u2013516 (2024).","journal-title":"Neurosci. Bull."},{"key":"1236_CR118","doi-asserted-by":"publisher","unstructured":"Morais, L. H., De Castro Fonseca, M. & Sampson, T. R. The gut microbiome in animal models of Parkinson\u2019s disease. in Integrative Omics in Parkinson\u2019s Disease 153\u2013169. https:\/\/doi.org\/10.1016\/B978-0-443-13550-7.00010-0 (Elsevier, 2025).","DOI":"10.1016\/B978-0-443-13550-7.00010-0"},{"key":"1236_CR119","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/nbt.3353","volume":"33","author":"L Xiao","year":"2015","unstructured":"Xiao, L. et al. A catalog of the mouse gut metagenome. Nat. Biotechnol. 33, 1103\u20131108 (2015).","journal-title":"Nat. Biotechnol."},{"key":"1236_CR120","doi-asserted-by":"crossref","unstructured":"Nagpal, R. et al. Comparative microbiome signatures and short-chain fatty acids in mouse, rat, non-human primate, and human feces. Front. Microbiol. 9, 2897 (2018).","DOI":"10.3389\/fmicb.2018.02897"},{"key":"1236_CR121","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2021.12.003","volume":"30","author":"BS Beresford-Jones","year":"2022","unstructured":"Beresford-Jones, B. S. et al. The Mouse Gastrointestinal Bacteria Catalogue enables translation between the mouse and human gut microbiotas via functional mapping. Cell Host Microbe 30, 124\u2013138.e8 (2022).","journal-title":"Cell Host Microbe"},{"key":"1236_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41564-024-01870-z","volume":"10","author":"G Fackelmann","year":"2025","unstructured":"Fackelmann, G. et al. Gut microbiome signatures of vegan, vegetarian and omnivore diets and associated health outcomes across 21,561 individuals. Nat. Microbiol. 10, 41\u201352 (2025).","journal-title":"Nat. Microbiol."},{"key":"1236_CR123","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","volume":"53","author":"A Kurilshikov","year":"2021","unstructured":"Kurilshikov, A. et al. Large-scale association analyses identify host factors influencing human gut microbiome composition. Nat. Genet. 53, 156\u2013165 (2021).","journal-title":"Nat. Genet."},{"key":"1236_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-46331-5","volume":"13","author":"M von S\u00fc\u00dfkind-Schwendi","year":"2023","unstructured":"von S\u00fc\u00dfkind-Schwendi, M. et al. Addition of soluble fiber to standard purified diets is important for gut morphology in mice. Sci. Rep. 13, 19340 (2023).","journal-title":"Sci. Rep."},{"key":"1236_CR125","doi-asserted-by":"publisher","first-page":"e0293487","DOI":"10.1371\/journal.pone.0293487","volume":"19","author":"L Schipper","year":"2024","unstructured":"Schipper, L. et al. Grain versus AIN: Common rodent diets differentially affect health outcomes in adult C57BL\/6j mice. PLoS ONE 19, e0293487 (2024).","journal-title":"PLoS ONE"},{"key":"1236_CR126","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio, A. & Schwarzschild, M. A. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 15, 1257\u20131272 (2016).","journal-title":"Lancet Neurol."},{"key":"1236_CR127","doi-asserted-by":"publisher","first-page":"e259198","DOI":"10.1001\/jamanetworkopen.2025.9198","volume":"8","author":"B Krzyzanowski","year":"2025","unstructured":"Krzyzanowski, B. et al. Proximity to golf courses and risk of Parkinson disease. JAMA Netw. Open 8, e259198 (2025).","journal-title":"JAMA Netw. Open"},{"key":"1236_CR128","doi-asserted-by":"publisher","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo, F. et al. Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE 5, e8762 (2010).","journal-title":"PLoS ONE"},{"key":"1236_CR129","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuro.2018.02.013","volume":"65","author":"ME Johnson","year":"2018","unstructured":"Johnson, M. E., Stringer, A. & Bobrovskaya, L. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson\u2019s disease. Neurotoxicology 65, 174\u2013185 (2018).","journal-title":"Neurotoxicology"},{"key":"1236_CR130","doi-asserted-by":"publisher","first-page":"20230849","DOI":"10.1515\/med-2023-0849","volume":"18","author":"N Mi","year":"2023","unstructured":"Mi, N. et al. Metabolomic analysis of serum short-chain fatty acid concentrations in a mouse of MPTP-induced Parkinson\u2019s disease after dietary supplementation with branched-chain amino acids. Open Med. 18, 20230849 (2023).","journal-title":"Open Med."},{"key":"1236_CR131","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2022-328166","volume":"72","author":"N Proch\u00e1zkov\u00e1","year":"2023","unstructured":"Proch\u00e1zkov\u00e1, N. et al. Advancing human gut microbiota research by considering gut transit time. Gut 72, 180\u2013191 (2023).","journal-title":"Gut"},{"key":"1236_CR132","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cca.2019.10.038","volume":"501","author":"B Sankowski","year":"2020","unstructured":"Sankowski, B. et al. Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson\u2019s disease. Clin. Chim. Acta 501, 165\u2013173 (2020).","journal-title":"Clin. Chim. Acta"},{"key":"1236_CR133","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","volume":"79","author":"J Jankovic","year":"2008","unstructured":"Jankovic, J. Parkinson\u2019s disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatry 79, 368\u2013376 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1236_CR134","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0022-510X(97)00100-7","volume":"151","author":"SY Ma","year":"1997","unstructured":"Ma, S. Y., R\u00f6ytt\u00e4, M., Rinne, J. O., Collan, Y. & Rinne, U. K. Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson\u2019s disease using disector counts. J. Neurol. Sci. 151, 83\u201387 (1997).","journal-title":"J. Neurol. Sci."},{"key":"1236_CR135","doi-asserted-by":"publisher","unstructured":"Kouli, A., Torsney, K. M. & Kuan, W.-L. Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. in Parkinson\u2019s Disease: Pathogenesis and Clinical Aspects 3\u201326. https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.2018.ch1 (Codon Publications, 2018).","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"key":"1236_CR136","first-page":"S297","volume":"9","author":"JM Boertien","year":"2019","unstructured":"Boertien, J. M., Pereira, P. A. B., Aho, V. T. E. & Scheperjans, F. Increasing comparability and utility of gut microbiome studies in Parkinson\u2019s disease: a systematic review. J. Park. Dis. 9, S297\u2013S312 (2019).","journal-title":"J. Park. Dis."},{"key":"1236_CR137","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/s12276-020-0473-2","volume":"52","author":"JC Park","year":"2020","unstructured":"Park, J. C. & Im, S.-H. Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics. Exp. Mol. Med. 52, 1383\u20131396 (2020).","journal-title":"Exp. Mol. Med."},{"key":"1236_CR138","doi-asserted-by":"publisher","unstructured":"Wong, M. K. et al. Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trial. mBio e0190425. https:\/\/doi.org\/10.1128\/mbio.01904-25 (2025).","DOI":"10.1128\/mbio.01904-25"},{"key":"1236_CR139","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480.e12 (2016).","journal-title":"Cell"},{"key":"1236_CR140","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.chom.2023.03.016","volume":"31","author":"EJ Culp","year":"2023","unstructured":"Culp, E. J. & Goodman, A. L. Cross-feeding in the gut microbiome: ecology and mechanisms. Cell Host Microbe 31, 485\u2013499 (2023).","journal-title":"Cell Host Microbe"},{"key":"1236_CR141","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00815-y","volume":"8","author":"S Sun","year":"2020","unstructured":"Sun, S., Jones, R. B. & Fodor, A. A. Inference-based accuracy of metagenome prediction tools varies across sample types and functional categories. Microbiome 8, 46 (2020).","journal-title":"Microbiome"},{"key":"1236_CR142","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-025-02091-0","volume":"13","author":"LB Bindels","year":"2025","unstructured":"Bindels, L. B. et al. A blueprint for contemporary studies of microbiomes. Microbiome 13, 95 (2025).","journal-title":"Microbiome"},{"key":"1236_CR143","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","volume":"27","author":"C Mirzayi","year":"2021","unstructured":"Mirzayi, C. et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat. Med. 27, 1885\u20131892 (2021).","journal-title":"Nat. Med."},{"key":"1236_CR144","doi-asserted-by":"publisher","first-page":"195","DOI":"10.5195\/jmla.2020.834","volume":"108","author":"JM Clark","year":"2020","unstructured":"Clark, J. M. et al. Improving the translation of search strategies using the Polyglot Search Translator: a randomized controlled trial. J. Med. Libr. Assoc. 108, 195\u2013207 (2020).","journal-title":"J. Med. Libr. Assoc."},{"key":"1236_CR145","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/00236772211045485","volume":"56","author":"S van der Mierden","year":"2022","unstructured":"van der Mierden, S. et al. Laboratory animals search filter for different literature databases: PubMed, Embase, Web of Science and PsycINFO. Lab. Anim. 56, 279\u2013286 (2022).","journal-title":"Lab. Anim."},{"key":"1236_CR146","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","volume":"104","author":"WM Bramer","year":"2016","unstructured":"Bramer, W. M., Giustini, D., de Jonge, G. B., Holland, L. & Bekhuis, T. De-duplication of database search results for systematic reviews in EndNote. J. Med. Libr. Assoc. 104, 240\u2013243 (2016).","journal-title":"J. Med. Libr. Assoc."},{"key":"1236_CR147","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jtbi.2006.04.017","volume":"242","author":"F Gosselin","year":"2006","unstructured":"Gosselin, F. An assessment of the dependence of evenness indices on species richness. J. Theor. Biol. 242, 591\u2013597 (2006).","journal-title":"J. Theor. Biol."},{"key":"1236_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v036.i03","volume":"36","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer, W. Conducting meta-analyses in R with the metafor package. J. Stat. Softw. 36, 1\u201348 (2010).","journal-title":"J. Stat. Softw."},{"key":"1236_CR149","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/jrsm.1628","volume":"14","author":"CJ van Lissa","year":"2023","unstructured":"van Lissa, C. J., van Erp, S. & Clapper, E. Selecting relevant moderators with Bayesian regularized meta-regression. Res. Synth. Methods 14, 301\u2013322 (2023).","journal-title":"Res. Synth. Methods"},{"key":"1236_CR150","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00213-023-06333-7","volume":"240","author":"EJ Heesbeen","year":"2023","unstructured":"Heesbeen, E. J. et al. The effect of SSRIs on fear learning: a systematic review and meta-analysis. Psychopharmacology 240, 2335\u20132359 (2023).","journal-title":"Psychopharmacology"},{"key":"1236_CR151","doi-asserted-by":"publisher","first-page":"e24260","DOI":"10.7554\/eLife.24260","volume":"6","author":"P-P Zwetsloot","year":"2017","unstructured":"Zwetsloot, P.-P. et al. Standardized mean differences cause funnel plot distortion in publication bias assessments. eLife 6, e24260 (2017).","journal-title":"eLife"},{"key":"1236_CR152","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s00213-024-06645-2","volume":"241","author":"EJ Heesbeen","year":"2024","unstructured":"Heesbeen, E. J. et al. The effect of SSRIs on unconditioned anxiety: a systematic review and meta-analysis of animal studies. Psychopharmacology 241, 1731\u20131755 (2024).","journal-title":"Psychopharmacology"},{"key":"1236_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans, C. R. et al. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med. Res. Methodol. 14, 43 (2014).","journal-title":"BMC Med. Res. Methodol."},{"key":"1236_CR154","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","volume":"30","author":"A Keshavarzian","year":"2015","unstructured":"Keshavarzian, A. et al. Colonic bacterial composition in Parkinson\u2019s disease. Mov. Disord. 30, 1351\u20131360 (2015).","journal-title":"Mov. Disord."},{"key":"1236_CR155","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/mds.26069","volume":"30","author":"F Scheperjans","year":"2015","unstructured":"Scheperjans, F. et al. Gut microbiota are related to Parkinson\u2019s disease and clinical phenotype. Mov. Disord. 30, 350\u2013358 (2015).","journal-title":"Mov. Disord."},{"key":"1236_CR156","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0428-y","volume":"9","author":"JR Bedarf","year":"2017","unstructured":"Bedarf, J. R. et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients. Genome Med. 9, 39 (2017).","journal-title":"Genome Med."},{"key":"1236_CR157","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","volume":"32","author":"EM Hill-Burns","year":"2017","unstructured":"Hill-Burns, E. M. et al. Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome. Mov. Disord. 32, 739\u2013749 (2017).","journal-title":"Mov. Disord."},{"key":"1236_CR158","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2017.04.019","volume":"1667","author":"F Hopfner","year":"2017","unstructured":"Hopfner, F. et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res. 1667, 41\u201345 (2017).","journal-title":"Brain Res."},{"key":"1236_CR159","doi-asserted-by":"publisher","first-page":"134297","DOI":"10.1016\/j.neulet.2019.134297","volume":"707","author":"F Li","year":"2019","unstructured":"Li, F. et al. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson\u2019s disease. Neurosci. Lett. 707, 134297 (2019).","journal-title":"Neurosci. Lett."},{"key":"1236_CR160","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnmol.2019.00171","volume":"12","author":"C Li","year":"2019","unstructured":"Li, C. et al. Gut microbiota differs between Parkinson\u2019s disease patients and healthy controls in Northeast China. Front. Mol. Neurosci. 12, 171 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"1236_CR161","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2021.10.011","volume":"480","author":"Z Li","year":"2022","unstructured":"Li, Z. et al. Oral, nasal, and gut microbiota in Parkinson\u2019s disease. Neuroscience 480, 65\u201378 (2022).","journal-title":"Neuroscience"},{"key":"1236_CR162","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","volume":"162","author":"VA Petrov","year":"2017","unstructured":"Petrov, V. A. et al. Analysis of gut microbiota in patients with Parkinson\u2019s disease. Bull. Exp. Biol. Med. 162, 734\u2013737 (2017).","journal-title":"Bull. Exp. Biol. Med."},{"key":"1236_CR163","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","volume":"33","author":"A Heintz-Buschart","year":"2018","unstructured":"Heintz-Buschart, A. et al. The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder. Mov. Disord. 33, 88\u201398 (2018).","journal-title":"Mov. Disord."},{"key":"1236_CR164","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","volume":"53","author":"A Lin","year":"2018","unstructured":"Lin, A. et al. Gut microbiota in patients with Parkinson\u2019s disease in southern China. Park. Relat. Disord. 53, 82\u201388 (2018).","journal-title":"Park. Relat. Disord."},{"key":"1236_CR165","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1528-y","volume":"16","author":"C-H Lin","year":"2019","unstructured":"Lin, C.-H. et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease. J. Neuroinflammation 16, 129 (2019).","journal-title":"J. Neuroinflammation"},{"key":"1236_CR166","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2018.02.016","volume":"70","author":"Y Qian","year":"2018","unstructured":"Qian, Y. et al. Alteration of the fecal microbiota in Chinese patients with Parkinson\u2019s disease. Brain Behav. Immun. 70, 194\u2013202 (2018).","journal-title":"Brain Behav. Immun."},{"key":"1236_CR167","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1093\/brain\/awaa201","volume":"143","author":"Y Qian","year":"2020","unstructured":"Qian, Y. et al. Gut metagenomics-derived genes as potential biomarkers of Parkinson\u2019s disease. Brain J. Neurol. 143, 2474\u20132489 (2020).","journal-title":"Brain J. Neurol."},{"key":"1236_CR168","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","volume":"44","author":"VTE Aho","year":"2019","unstructured":"Aho, V. T. E. et al. Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression. EBioMedicine 44, 691\u2013707 (2019).","journal-title":"EBioMedicine"},{"key":"1236_CR169","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","volume":"34","author":"M Barichella","year":"2019","unstructured":"Barichella, M. et al. Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism. Mov. Disord. 34, 396\u2013405 (2019).","journal-title":"Mov. Disord."},{"key":"1236_CR170","doi-asserted-by":"crossref","unstructured":"Jin, M. et al. Analysis of the gut microflora in patients with Parkinson\u2019s disease. Front. Neurosci. 13, 1184 (2019).","DOI":"10.3389\/fnins.2019.01184"},{"key":"1236_CR171","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","volume":"65","author":"D Pietrucci","year":"2019","unstructured":"Pietrucci, D. et al. Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients. Park. Relat. Disord. 65, 124\u2013130 (2019).","journal-title":"Park. Relat. Disord."},{"key":"1236_CR172","first-page":"1","volume":"5","author":"S Weis","year":"2019","unstructured":"Weis, S. et al. Effect of Parkinson\u2019s disease and related medications on the composition of the fecal bacterial microbiota. Npj Park. Dis. 5, 1\u20139 (2019).","journal-title":"Npj Park. Dis."},{"key":"1236_CR173","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00775-7","volume":"18","author":"F Baldini","year":"2020","unstructured":"Baldini, F. et al. Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. BMC Biol. 18, 62 (2020).","journal-title":"BMC Biol."},{"key":"1236_CR174","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","volume":"35","author":"MS Cirstea","year":"2020","unstructured":"Cirstea, M. S. et al. Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease. Mov. Disord. 35, 1208\u20131217 (2020).","journal-title":"Mov. Disord."},{"key":"1236_CR175","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fneur.2020.01041","volume":"11","author":"A Cosma-Grigorov","year":"2020","unstructured":"Cosma-Grigorov, A. et al. Changes in gastrointestinal microbiome composition in PD: a pivotal role of covariates. Front. Neurol. 11, 1041 (2020).","journal-title":"Front. Neurol."},{"key":"1236_CR176","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki, H. et al. Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov. Disord. 35, 1626\u20131635 (2020).","journal-title":"Mov. Disord."},{"key":"1236_CR177","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fneur.2020.00137","volume":"11","author":"T Ren","year":"2020","unstructured":"Ren, T. et al. Gut microbiota altered in mild cognitive impairment compared with normal cognition in sporadic Parkinson\u2019s disease. Front. Neurol. 11, 137 (2020).","journal-title":"Front. Neurol."},{"key":"1236_CR178","doi-asserted-by":"publisher","first-page":"e00561","DOI":"10.1128\/mSystems.00561-20","volume":"5","author":"S Vascellari","year":"2020","unstructured":"Vascellari, S. et al. Gut microbiota and metabolome alterations associated with Parkinson\u2019s disease. mSystems 5, e00561\u201320 (2020).","journal-title":"mSystems"},{"key":"1236_CR179","doi-asserted-by":"publisher","first-page":"108807","DOI":"10.1016\/j.celrep.2021.108807","volume":"34","author":"D Rosario","year":"2021","unstructured":"Rosario, D. et al. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson\u2019s disease. Cell Rep. 34, 108807 (2021).","journal-title":"Cell Rep."},{"key":"1236_CR180","doi-asserted-by":"publisher","first-page":"105187","DOI":"10.1016\/j.micpath.2021.105187","volume":"160","author":"Z Yan","year":"2021","unstructured":"Yan, Z. et al. Alterations of gut microbiota and metabolome with Parkinson\u2019s disease. Microb. Pathog. 160, 105187 (2021).","journal-title":"Microb. Pathog."},{"key":"1236_CR181","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00415-021-10657-9","volume":"269","author":"M Lubomski","year":"2022","unstructured":"Lubomski, M. et al. The impact of device-assisted therapies on the gut microbiome in Parkinson\u2019s disease. J. Neurol. 269, 780\u2013795 (2022).","journal-title":"J. Neurol."},{"key":"1236_CR182","first-page":"2441","volume":"12","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. Parkinson\u2019s disease and the gut microbiome in rural California. J. Park. Dis. 12, 2441\u20132452 (2022).","journal-title":"J. Park. Dis."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01236-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01236-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01236-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T14:04:08Z","timestamp":1769609048000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01236-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":182,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01236-0","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"7 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author J.G. is a part-time employee of Danone Global Research and Innovation Center. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31"}}